Aptamers in the Therapeutics and Diagnostics Pipelines

Area of Science:

• Biotechnology
• Molecular Biology
• Nucleic Acid Chemistry

Background:

• Aptamers are single-stranded DNA or RNA oligonucleotides with high specificity and affinity for targets.
• They possess advantages like small size, low immunogenicity, and chemical stability, enhancing their clinical utility.
• Aptamer technology has evolved significantly since the 1990s, with applications in treating diseases like cancer and macular degeneration.

Purpose of the Study:

• To provide a comprehensive overview of aptamer technology.
• To highlight the therapeutic and diagnostic potential and challenges of aptamers.
• To review aptamers that have progressed to clinical trials or diagnostic markets.

Main Methods:

• Literature review of aptamer applications in therapeutics and diagnostics.
• Analysis of aptamer properties, including specificity, affinity, and stability.
• Examination of aptamers' translational potential in clinical settings.

Main Results:

• Aptamers demonstrate significant potential in diagnostics, improving speed and accuracy on point-of-care platforms.
• Several aptamers have advanced into clinical trials for various diseases.
• Aptamer technology is a rapidly growing field with diverse applications.

Conclusions:

• Aptamers are versatile molecules with substantial therapeutic and diagnostic promise.
• Overcoming challenges in aptamer development is key to realizing their full clinical potential.
• Continued research and development are expected to expand aptamer-based medical solutions.